#USA #New York #Levi & Korsinsky #QuidelOrtho #QDEL

QuidelOrtho Under Investigation After Recent Stock Decline

QuidelOrtho Corporation (NASDAQ: QDEL) is currently under investigation following a significant decline in its stock price, which dropped approximately 14% after the company reported its third-quarter results for 2026. The result of the third quarter included a revised revenue outlook and a restructuring program which has raised concerns among shareholders.

In the wake of these results, Levi & Korsinsky, a law firm known for representing investors, has begun an investigation into possible violations of securities laws. This inquiry aims to determine if QuidelOrtho misled investors regarding its financial outlook, particularly its liquidity and revenue expectations for the entire year. Following the report, the company’s shares have fallen significantly, leading to adverse impacts for many shareholders.

On August 7, 2026, QuidelOrtho had filed a quarterly report indicating that its cash reserves and operational cash flow would meet its immediate capital needs for at least the next year. However, the company indicated a negative operating cash flow of $143.6 million, along with $426.5 million still available from its revolving credit facility. This financial status has led to a narrowed revenue expectation as stated in the latest quarterly report, alongside the announcement of a restructuring program purported to cost around $100 million through 2027.

For shareholders who experienced financial losses due to the stock price drop, it is essential to understand that you may have rights. Levi & Korsinsky is actively encouraging those affected to investigate their options for recovering losses. Prospective participants are urged to gather records that outline share purchase dates, amounts, and prices.

What Does This Mean for Investors?

Investors with shares in QuidelOrtho are advised to be informed about their standing. The investigation centers on whether the statements made by QuidelOrtho prior to the corrective disclosure could be classified as materially false or misleading. Specifically, it addresses whether these statements induced investors to purchase securities at inflated prices based on overly optimistic information about the company’s financial health and market potential.

Key Questions Raised by the Investigation:

• - What statements are being targeted as misleading? The primary focus is on disclosures regarding the company’s financial projections and operational capabilities, particularly in relation to liquidity and full-year revenue forecasts.
• - When was the alleged misleading occurring? The investigation specifically examines statements made before the recent disclosures that have altered investor perception and behavior.
• - Who qualifies for participation? Eligible participants are those who purchased QDEL stock prior to the decline and suffered financial losses, regardless of whether they still hold their shares.

Next Steps for Investors

For shareholders wishing to take action, there’s no immediate requirement to engage professionally. However, you should begin to compile documentation, such as brokerage statements reflecting purchase dates and sale activities, to present if you decide to pursue this investigation further. Additionally, there is no cost associated with participating in this investigation, as fees will be contingent upon successful recovery efforts, with expenses needing court approval.

Conclusion

As this investigation unfolds, QuidelOrtho’s stakeholders will need to stay abreast of all developments, particularly how the results may influence their investments. Those who feel financially impacted by the recent stock decline should reach out to legal professionals for consultation on their potential recovery avenues. If you believe you qualify, gathering your transaction records is a prudent first step as the investigation progresses. The ongoing watch on QuidelOrtho's stock will likely continue to draw interest, particularly as the company navigates its restructuring efforts and revised financial expectations.